胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤进展的相关性

doi:10.6040/j.issn.1671-7554.0.2019.586

摘要/Abstract

摘要： 目的探讨在活体动物体内人胃癌组织间充质干细胞(hGC-MSCs)对SGC-7901胃癌荷瘤鼠模型肿瘤进展的作用。方法将实验鼠分为对照组hGC-MSCs组、实验组SGC-7901组和 hGC-MSCs+SGC-7901组。分别将相应的细胞悬液接种于实验鼠右侧背部皮下,观察肿瘤是否发生,肿瘤发生时间及肿瘤大小的变化;从不同的层面及角度,依次采用免疫组织化学染色、实时聚合酶链反应、蛋白质印迹法检测基质金属蛋白酶和增殖细胞核抗原在各实验鼠组中的表达水平。结果对照组中没有发生肿瘤,而实验组中hGC-MSCs+SGC-7901组与SGC-7901组相比,肿瘤发生时间短、生长速度快及肿瘤体积大,差异有统计学意义(P<0.05)。免疫组织化学染色结果显示增殖细胞核抗原在SGC-7901组和hGC-MSCs+SGC-7901组中的平均吸光度值分别为0.358±0.009、0.481±0.030,差异有统计学意义(P<0.05),基质金属蛋白酶-9在两组中的平均吸光度值分别为0.359±0.033、0.520±0.038,差异有统计学意义(P<0.05);实时聚合酶链反应证实hGC-MSCs能够上调PCNA、MMP-9的表达(P<0.01);Western blotting检测显示增殖细胞核抗原在两组中蛋白条带灰度值分别为0.756±0.039、0.847±0.048,差异有统计学意义(P<0.05)。基质金属蛋白酶-9在两组中蛋白条带灰度值分别为0.692±0.079、0.866±0.010,差异有统计学意义(P<0.05)。结论 hGC-MSCs在体内通过上调增殖细胞核抗原和基质金属蛋白酶-9的表达水平,从而参与肿瘤的发生及发展。

关键词: 胃癌, 间充质干细胞, 增殖细胞核抗原, 基质金属蛋白酶

Abstract: Objective To investigate the effects of human gastric cancer mesenchymal stem cells(hGC-MSCs)on the occurrence and development of gastric cancer cell line SGC-7901 in vivo. Methods The nude mice were divided into hGC-MSCs group, SGC-7901 group and hGC-MSCs+SGC-7901 group. The cell suspension was inoculated subcutaneously on the right back of the experimental mice to observe the occurrence of tumor, time of occurrence and change of tumor size. The expression levels of proliferating cell nuclear antigen(PCNA)and matrix metalloproteinase-9(MMP-9)were detected with immunohistochemical staining, real-time polymerase chain reaction(RT-PCR)and Western blotting. Results No tumor occurred in the control group. The hGC-MSCs+SGC-7901 group had shorter time of tumor occurrence, faster tumor growth and larger tumor size than the SGC-7901 group (P<0.05). The immunohistochemistry results showed that the average optical density of PCNA in SGC-7901 group and hGC-MSCs+SGC-7901 group was 0.358±0.009 and 0.481±0.030, respectively; the average optical density of MMP-9 in these two groups was 0.359±0.033 and 0.520±0.038, respectively (P<0.05). Real-time PCR demonstrated that hGC-MSCs could upregulate 山东大学学报 (医学版)57卷9期 -赵鸿渐,等.胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤荷瘤鼠肿瘤进展的相关性研究 \=-the expressions of PCNA and MMP-9 (P<0.01). Western blotting showed that the PCNA protein band grayscale in SGC-7901 group and hGC-MSCs+SGC-7901 group was 0.756±0.039 and 0.847±0.048, respectively; the MMP-9 protein band grayscale in these two groups was 0.692±0.079 and 0.866±0.010, respectively (P<0.05). Conclusion HGC-MSCs participate in the occurrence and development of tumors by up-regulating the expression levels of PCNA and MMP-9 in vivo.

Key words: Gastric cancer, Mesenchymal stem cells, Proliferating cell nuclear antigen, Matrix metalloproteinase

中图分类号:

R574

赵鸿渐,周继军,苏庆亮,赵硕,李玉明. 胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤进展的相关性[J]. 山东大学学报 (医学版), 2019, 57(9): 69-73.

ZHAO Hongjian, ZHOU Jijun, SU Qingliang, ZHAO Shuo, LI Yuming. Correlation between human gastric cancer mesenchymal stem cells and tumor progression in SGC-7901 tumor-bearing mice[J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 69-73.

参考文献

[1] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59(4): 225-249.
[2] 张明凯, 李玉明, 蒋宏, 等. 人胃癌组织中间充质干细胞的生物学稳定性分析[J]. 中华临床医师杂志(电子版), 2012, 6(16): 4603-4606. ZHANG Mingkai, LI Yuming, JIANG Hong, et al. The biological stability characteristics of mesenchymal stem cells from human gastric cancer research[J]. Chin J Clin Electron Ed, 2012, 6(16): 4603-4606.
[3] Cao HL, Xu WR, Qian H, et al. Mesenchymal stem cell-like cells derived from human gastric cancer tissues[J]. Cancer Lett, 2009, 274(1): 61-71.
[4] 王凯, 李玉明, 张明凯, 等. 人胃癌组织中间充质干细胞对胃癌细胞株SGC-7901增殖与侵袭能力的影响[J]. 中华实验外科杂志, 2014, 31(3): 480-482. WANG Kai, LI Yuming, ZHANG Mingkai, et al. Effects of mesenchymal stem cells from human gastric cancer on proliferation and invasion of human gastric cancer cell strain SGC-7901[J]. Chin J Exp Surg, 2014, 31(3): 480-482.
[5] Han ZP, Jing YY, Zhang SS, et al. The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth[J]. Cell Biosci, 2012, 2(1): 8.
[6] Ji RB, Zhang B, Zhang X, et al. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer[J]. Cell Cycle, 2015, 14(15): 2473-2483.
[7] Cao HL, Xu WR, Qian H, et al. Mesenchymal stem cell-like cells derived from human gastric cancer tissues[J]. Cancer Lett, 2009, 274(1): 61-71.
[8] Wu CY, Wu MS, Chiang EP, et al. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution[J]. Clin Cancer Res, 2007, 13(7): 2054-2060.
[9] 周烨, 朱慰祺. 增殖细胞核抗原与胃癌浸润、转移和预后的关系[J]. 实用癌症杂志, 1998, 13(3): 232-234.
[10] Doucette T, Rao G, Yang YH, et al. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model[J]. Neoplasia, 2011, 13(8): 716-725.
[11] Loebinger MR, Eddaoudi A, Davies D, et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer[J]. Cancer Res, 2009, 69(10): 4134-4142.
[12] 庞一琳, 张斌, 陈虎. 间充质干细胞与肿瘤细胞相互作用: 促进还是抑制[J]. 中华细胞与干细胞杂志(电子版), 2013, 3(1): 31-38.
[13] Tian LL, Yue WM, Zhu F, et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo[J]. J Cell Physiol, 2011, 226(7): 1860-1867.
[14] Ramasamy R, Lam EW, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth[J]. Leukemia, 2007, 21(2): 304-310.
[15] 李国才, 武金才, 孙冰生, 等. 骨髓间充质干细胞对人肝癌细胞系MHCC97-H增殖能力的影响[J]. 中华实验外科杂志, 2008, 25(7): 823-825. LI Guocai, WU Jincai, SUN Bingsheng, et al. The effect of mesenchymal stem cells on the proliferation of MHCC97-H cell fine[J]. Chin J Exp Surg, 2008, 25(7): 823-825.
[16] Ma Y, Hao XM, Zhang S, et al. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells[J]. Breast Cancer Res Treat, 2012, 133(2): 473-485.
[17] Klopp AH, Gupta A, Spaeth E, et al. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?[J]. Stem Cells, 2011, 29(1): 11-19.
[18] Chien J, Kuang R, Landen C, et al. Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment[J]. Front Oncol, 2013, 3: 251.
[19] Kwee RM, Kwee TC. Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer[J]. World J Gastroenterol, 2014, 20(7): 1650-1656.

相关文章 15

[1]	付佳,王路路,胡帅,陈哲平,刘东义,李青松,卢国栋,张贺,赵鑫,冯昌. 不同入路腰方肌阻滞对胃癌根治患者术后恢复的影响[J]. 山东大学学报 (医学版), 2022, 60(8): 50-57.
[2]	包舒晴,杨明月,刘端瑞,汪运山,郏雁飞. NOX4在幽门螺旋杆菌诱导胃癌细胞ROS中的作用[J]. 山东大学学报 (医学版), 2022, 60(6): 19-25.
[3]	王景,谢艳,李培龙,杜鲁涛,王传新. GZMB基因cg16212145位点的异常甲基化芯片测定对胃癌早筛的价值[J]. 山东大学学报 (医学版), 2022, 60(6): 26-34.
[4]	高惠茹,杜甜甜,王允山,杜鲁涛,王传新. 基于单细胞转录组测序数据分析胃癌调节性T细胞特征[J]. 山东大学学报 (医学版), 2022, 60(5): 43-49.
[5]	王芳,陈华,商丽红,李茹月,李咏梅,杨玉娥,哈春芳. U0126对子宫内膜异位症大鼠MEK/ERK/NF-κB通路及增殖侵袭的影响[J]. 山东大学学报 (医学版), 2021, 59(9): 148-154.
[6]	褚晏,刘端瑞,朱文帅,樊荣,马晓丽,汪运山,郏雁飞. DNA甲基化转移酶在胃癌中的表达及其临床意义[J]. 山东大学学报 (医学版), 2021, 59(7): 1-9.
[7]	罗兵. EB病毒对胃癌表观遗传学的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 30-39.
[8]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[9]	支梦伟,江志伟,戴新娟,王刚,程伟. 加速康复外科指导下胃癌患者围手术期心率变异度的临床观察[J]. 山东大学学报 (医学版), 2020, 58(11): 85-91.
[10]	李乐平,崔怀平,商亮. 加速康复外科在胃肠外科手术中的应用[J]. 山东大学学报 (医学版), 2019, 57(9): 5-11.
[11]	房鹏,王刚,赵健,刘江,王海锋,周嘉晖,江志伟. 加速康复外科减少胃癌患者术后重症监护病房住院时间的临床观察[J]. 山东大学学报 (医学版), 2019, 57(9): 28-32.
[12]	董昌正,周伟,李风周,臧义丰,丁印鲁. 全腹腔镜下全胃+胆囊+阑尾切除经自然腔道取标本手术1例[J]. 山东大学学报 (医学版), 2019, 57(7): 122-124.
[13]	张志慧,刘延国,肖丰启,马道新,王秀问. 顺铂对肿瘤间充质干细胞中IL-6表达的调控及p38MAPK通路参与机制[J]. 山东大学学报 (医学版), 2019, 57(3): 1-6.
[14]	侯巧妮,马会明,相丽,何艳桃,徐仙,陈冬梅,张雪玉. 人胎盘间充质干细胞移植对化疗所致卵巢早衰大鼠卵巢功能的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 52-60.
[15]	黄平,张坤,李芳,黄国宝,延冰,肖东杰,汪运山,刘华. 脐带和脂肪源性间充质干细胞生物学特性比较[J]. 山东大学学报 (医学版), 2018, 56(3): 72-78.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed